|
UNG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72750702631674E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.87530024631633E-13 |
| Normal-vs-Stage2 |
8.338200E-02 |
| Normal-vs-Stage3 |
1.62314606200198E-13 |
| Normal-vs-Stage4 |
1.62536650805123E-12 |
| Stage1-vs-Stage2 |
1.000540E-03 |
| Stage1-vs-Stage3 |
1.801240E-01 |
| Stage1-vs-Stage4 |
2.844800E-04 |
| Stage2-vs-Stage3 |
1.443450E-04 |
| Stage2-vs-Stage4 |
9.99389999978284E-07 |
| Stage3-vs-Stage4 |
5.875900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.18645110297666E-12 |
| Normal-vs-AfricanAmerican |
1.8645999999567E-06 |
| Normal-vs-Asian |
3.99236199655206E-13 |
| Caucasian-vs-AfricanAmerican |
8.568800E-01 |
| Caucasian-vs-Asian |
5.266000E-02 |
| AfricanAmerican-vs-Asian |
4.020400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58899999824769E-08 |
| Normal-vs-Female |
1.63380420303838E-12 |
| Male-vs-Female |
4.963600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04969374806296E-12 |
| Normal-vs-Age(41-60Yrs) |
1.18179910302274E-11 |
| Normal-vs-Age(61-80Yrs) |
4.72560000019939E-07 |
| Normal-vs-Age(81-100Yrs) |
7.788800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.191600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.858100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.367600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.548210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.955600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.554600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.000370E-04 |
| Classical-VS-Follicular |
2.020000E-04 |
| Classical-VS-Other |
6.660400E-01 |
| Classical-VS-Normal |
1.63324909152607E-12 |
| Tall-VS-Follicular |
3.64099994598632E-09 |
| Tall-VS-Other |
2.154200E-01 |
| Tall-VS-Normal |
2.44249065417534E-15 |
| Follicular-VS-Other |
5.493400E-01 |
| Follicular-VS-Normal |
1.017300E-03 |
| Other-VS-Normal |
3.243900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6586999995738E-08 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
5.29520000069894E-08 |
|
|
